Xuefang Wang, MSc, MBA
Director, Bioanalytical Services
Xuefang Wang is Director and Head of Clinical Large Molecule Bioanalysis, with 15 years of experience in integrated PK, PD, and immunogenicity testing for large molecule therapeutics. Her expertise spans bispecific antibodies, ADCs, fusion proteins, CAR-T, AAV, oligonucleotides, vaccines, mRNA, and oncolytic viruses. She has developed biomarker platforms supporting soluble, cellular, molecular, and tissue-level analyses across oncology, immunology, neurology, and metabolic diseases. Her immunogenicity expertise includes anti-drug antibody and neutralizing antibody assays with cell-based functional testing. With 13 years of GLP bioanalytical experience, she supports work aligned with GLP, CAP, 21 CFR Part 11, and global regulatory requirements. Her team has supported more than 100 clients and 20 antiviral drugs through market approval. She earned her MSc at Shanghai Jiao Tong University.